ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,701 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentEpalingesMoleSense Sàrl
MoleSense Sàrl Logo
Verified· 3 sourcesTrust Score
Summary

About the company

MoleSense Sàrl develops a molecular wearable for maternity health monitoring before, during and after pregnancy. The company measures hormonal and inflammatory biomarkers non-invasively through sweat analysis to track biological changes over time.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentMedical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.8/5

MoleSense Sàrl

✓ Offered5
Molecular Wearable for Maternity Health
Molecular wearable for maternity health with continuous, non-invasive measurement of hormonal and inflammatory biomarkers through sweat analysis; for pregnancy, fertility, menopause and postpartum.
Continuous Molecular Monitoring
Continuous monitoring of hormonal and inflammatory changes over time, with longitudinal biomarker data for earlier detection, risk assessment and clinical decision-making.
Sweat-Based Biomarker Analysis
Sweat-based analysis of hormones and inflammatory biomarkers using epidermal microfluidics and DNA-based biosensors for targeted, non-invasive sampling.
Wearable System Design
Development of an integrated wearable system with housing, custom electronics, skin-safe patch and wireless data transmission for everyday use.
Data Analytics and AI for Biomarkers
Data-driven analysis of longitudinal hormone and biomarker trends with personalised baselines to identify relevant deviations and patterns.
Trust & reputation

ranQ Trust Score of MoleSense Sàrl: 3.8 out of 5.0

Trust Score3.8/ 5.0

High

x

Data basis 54% · As of October 2026

MoleSense Sàrl has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
MoleSense Sàrl scores 50.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.25.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
MoleSense Sàrl scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
MoleSense Sàrl scores 66.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.66.74%
Qualifications+0.00

MoleSense Sàrl reaches a ranQ Trust Score of 3.8 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

July 24, 2026Media
MoleSense and Impli selected for SPRIND Challenge on Continuous Hormone Monitoring
startupticker.ch
June 25, 2026Media
MoleSense enters Biopôle’s Investment Programme
startupticker.ch
February 4, 2026Media
MoleSense wins over Vanguard Accelerator
startupticker.ch
December 1, 2025Media
MoleSense gewinnt Swiss Innovation Challenge 2025
startupticker.ch
October 29, 2025Media
MoleSense to advance the first molecular wearable for maternity care
startupticker.ch

Knowledge

No knowledge articles yet

Once MoleSense Sàrl has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

MoleSense Sàrl in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank MoleSense Sàrl by reviews, experience and specialisations.

Is this your company?

Claim the company profile of MoleSense Sàrl to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 5
1066 Epalinges

At a glance

Legal form
Limited Liability Company
UID
CHE-338.667.467
Founded
2025 · 1 year
Last commercial register change
August 26, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    VS
    VivoArchitect Sàrl
    Epalinges
    NB
    ND BioSciences SA
    Epalinges
    PS
    Pollux Scientific SA
    Epalinges
    AS
    Archeotech S.A.
    Epalinges
    AS
    ActLight SA
    Lausanne
    CA
    Cassiopee Applied Analytical Systems Sàrl
    Carrouge Vd
    HD
    Health Data Safe
    Morges
    GG
    Granich Global Health Consulting
    Coppet